Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 3,979,035 |
|
|||||
| News | - | ||||||
| Day High | 64.54 | Low High |
|||||
| Day Low | 64.40 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Alpine Immune Sciences Inc | ALPN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.11 | 0.17% | 64.54 | 17:36:19 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 64.43 | 64.40 | 64.54 | 64.55 | 64.43 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 24,168 | 3,979,035 | US$ 64.41 | US$ 256,295,804 | - | 6.71 - 64.57 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:38:08 | 1 | US$ 64.50 | USD |
Alpine Immune Sciences (ALPN) Options Flow Summary
Alpine Immune Sciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.75B | 58.10M | - | 58.88M | -32.18M | -0.55 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alpine Immune Sciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALPN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 64.36 | 64.57 | 64.34 | 64.43 | 3,094,841 | 0.18 | 0.28% |
| 1 Month | 41.32 | 64.57 | 34.25 | 56.60 | 4,061,185 | 23.22 | 56.20% |
| 3 Months | 22.45 | 64.57 | 21.92 | 46.81 | 2,240,136 | 42.09 | 187.48% |
| 6 Months | 10.00 | 64.57 | 8.33 | 37.74 | 1,474,122 | 54.54 | 545.40% |
| 1 Year | 7.47 | 64.57 | 6.71 | 33.88 | 863,703 | 57.07 | 763.99% |
| 3 Years | 11.00 | 64.57 | 4.82 | 28.98 | 354,993 | 53.54 | 486.73% |
| 5 Years | 7.14 | 64.57 | 2.05 | 25.05 | 269,788 | 57.40 | 803.92% |
Alpine Immune Sciences Description
| Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202. |
